Protalix Biotherapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Protalix Biotherapeutics shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.4M | 4.0M | 1.10 |
| 2023-06-30 | $4.8M | 4.0M | 1.20 |
| 2023-03-31 | $4.7M | 4.0M | 1.18 |
| 2022-12-31 | $4.2M | 4.0M | 1.05 |
| 2022-09-30 | $4.2M | 4.0M | 1.05 |
| 2022-06-30 | $4.2M | 4.0M | 1.05 |
| 2022-03-31 | $4.0M | 4.0M | 1.00 |
| 2021-12-31 | $4.0M | 4.0M | 1.00 |
| 2021-09-30 | $4.0M | 4.0M | 1.00 |
Top funds holding Protalix Biotherapeutics
View all funds holding Protalix Biotherapeutics